Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Sinovac Takes Steps toward Producing Swine Flu Vaccine

publication date: May 1, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinovac Biotech (北京科兴生物制品有限公司) has taken action to apply its vaccine technology to the currently threatening strain of influenza, H1N1, commonly referred to as Swine flu. The company expects to receive a sample of the flu soon, which will enable Sinovac to begin manufacturing vaccine. Although Sinovac did not supply a time line for the process, a release quoted Weidong Yin, Sinovac’s Chairman, President and CEO, as saying, “Once this vaccine strain is available from the global health authorities, we will be ready to produce vaccine as needed." More details...

Stock Symbol: (NYSE Amex: SVA)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners